References
- Al-Hammadi, A.; Al-Ismaily, A.; Al-Ali, S. Topical, Biological and Clinical Challenges in the Management of Patients with Acne Vulgaris. SQU Med J. 2016, 16(2), 78–90. DOI: https://doi.org/10.18295/squmj.2016.16.02.004.
- Lichtenberger, R.; Simpson, M. A.; Smith, C.; Barker, J.; Navarini, A. A. Genetic Architecture of Acne Vulgaris. J. Eur. Acad. Dermatol. Venereol. 2017 Dec, 31(12), 1978–1990. doi:https://doi.org/10.1111/jdv.14385.
- Younis, S.; Javed, Q. Interleukin- 6 and interleukin-1A Gene Promoter Polymorphism Is Assochiated with the Pathogenesis of Acne Vulgaris. Arch Dermatol Res. 2015, 307(4), 365–370. DOI: https://doi.org/10.1007/s00403-014-1519-x.
- Sabat, R.;. IL-10 Family of Cytokines. Cytokine Growth Factor Rev. 2010, 21(5), 315–324. DOI: https://doi.org/10.1016/j.cytogfr.2010.11.001.
- Camarillo, G.-F.; Carballeda, J.-F.; Granados, J.; Fonseca-Camarillo, G.; Furuzawa-Carballeda, J.; Granados, J.; Yamamoto-Furusho, J.-K. Expression of Interleukin (IL)-19 and IL-24 in Inflammatory Bowel Disease Patients: A Cross-sectional Study. Clin. Exp. Immunol. 2014, 64–75. DOI: https://doi.org/10.1111/cei.12285.
- Grange, P.; Weill, B.; Dupin, N.; Batteux, F. Does Inflammatory Acne Result from Imbalance in the Keratinocyte Innate Immune Response? Microbes Infect. 2010, 12(14–15), 1085–1090. DOI: https://doi.org/10.1016/j.micinf.2010.07.015.
- Jordan, W.; Eskdale, J.; Boniotto, M. Human IL-19 Regulates Immunity through Auto-induction of IL-19 and Production of IL-10. Eur J Immunol. 2005, 35(5), 1576–1582. DOI: https://doi.org/10.1002/eji.200425317.
- Mochtar, M.; Murasmita, A.; Irawanto, M. The Difference in Interleukin-19 Serum on Degrees of Acne Vulgaris Severity. Int J Inf. 2018, 20(8), 16–20. DOI: https://doi.org/10.1155/2018/4141579.
- Saleh, H. M.; Deif, M. A.; El-Husseiny, R. M. Assessment of Serum Interleukin-19 in Acne Vulgaris Patients of Different Clinical Severities. J Cosmet Dermat in press. 2021. DOI: https://doi.org/10.1111/jocd.13977.
- Strauss, J.; Krowchuk, D.; Leyden, J.; Lucky, W.; Shalita, A.; Siegfried, E.; Thiboutot, M.; Van Voorhees, A.; Beutner, K.; Sieck, C.;, et al. Guidelines of Care for Acne Vulgaris Management. J. AM. Acad. Dermtol. 2007, 56(4), 651–663. DOI: https://doi.org/10.1016/j.jaad.2006.08.048.
- Pokharel, G.; Harish, B. Acne Vulgaris: Knowledge and Attitude among Nepali School Students. Int J Nurs Res Practice. 2014, 1(1), 29–33. http://www.uphtr.com/IJNRP/home.
- Dreno, B.; Gollnick, H.; Kang, S.; Thiboutot, D.; Bettoli, V.; Torres, V.; Leyden, J. Understanding Innate Immunity and Inflammation in Acne: Implications for Management. EurAcadDermatolVenereol. 2015, 29(4), 3–11. DOI: https://doi.org/10.1111/jdv.13190.
- Awad, S.; Tawfik, Y.; El-Mokhtar, M.; El-Gazzar, A.; Abdel Motaleb, A. Activation of Janus Kinase Signaling Pathway in Acne Lesions. DermatolTher. 2020, 19, e14563. DOI: https://doi.org/10.1111/dth.14563.
- Konrad, R.; Higgs, R.; Rodgers, G. Assessment and Clinical Relevance of Serum IL-19 Levels in Psoriasis and Atopic Dermatitis Using a Sensitive and Specific Novel Immunoassay. Sci Rep. 2019, 9, 1–5. DOI: https://doi.org/10.1038/s41598-019-41609-z.
- Oka, T.; Sugaya, M.; Takahashi, N. Increased Interleukin-19 Expression in Cutaneous T-cell Lymphoma and Atopic Dermatitis. ActaDermato-Venereologica. 2017, 97(8–9), 1172–1177. DOI: https://doi.org/10.2340/00015555-2723.
- A Global Reference for Human Genetic Variation. Nature 2015, 526 (7571), 68–74. DOI: https://doi.org/10.1038/nature15393.
- Takahashi, H.; Tsuji, H.; Hashimoto, Y. Serum Cytokines and Growth Factor Levels in Japanese Patients with Psoriasis. Clin Exp Dermatol. 2010, 35, 645–649. DOI: https://doi.org/10.1111/j.1365-2230.2009.03704.x.
- Liao, S.; Cheng, Y.; Wang, Y. IL-19 Induced Th2 Cytokines and Was Up-regulated in Asthma Patients. J Immunol. 2004, 173, 6712–6718. DOI: https://doi.org/10.4049/jimmunol.173.11.6712.
- Sa, S.; Valdez, P.; Wu, J. The Effects of IL-20 Subfamily Cytokines on Reconstituted Human Epidermis Suggest Potential Roles in Cutaneous Innate Defense and Pathogenic Adaptive Immunity in Psoriasis. J Immunol. 2007, 178, 2229–2240. DOI: https://doi.org/10.4049/jimmunol.178.4.2229.
- Hsing, C.; Hsu, C.; Chen, W. Expression of IL-19 Correlates with Th2 Cytokines in Uraemic Patients. Nephrol. Dial. Transplant. 2007, 22, 2230–2238. DOI: https://doi.org/10.1093/ndt/gfm179.
- Galimova, E.; Rätsep, R.; Traks, T. Interleukin‐10 Family Cytokines Pathway: Genetic Variants and Psoriasis. Br. J. Dermatol. 2017, 176(6), 1577–1587. DOI: https://doi.org/10.1111/bjd.15363.
- Yamamoto-Furusho, J.; Álvarez-León, E.; Fragoso, J. Protective Role of Interleukin-19 Gene Polymorphisms in Patients with Ulcerative Colitis. Hum. Immunol. 2011, 72(11), 1029–1032. DOI: https://doi.org/10.1016/j.humimm.2011.08.013.
- Kõks, S.; Kingo, K.; Vabrit, K. Possible Relations between the Polymorphisms of the Cytokines IL‐19, IL‐20 and IL‐24 and Plaque‐type Psoriasis. Genes Immun. 2005, 6, 407–415. DOI: https://doi.org/10.1038/sj.gene.6364216.
- Lin, J.; Qin, H.; Wang, Y.; Liang, J.; Xu, J. Analysis of Interleukin 19 Serum Levels and Single Nucleotide Polymorphisms in Systemic Lupus Erythematosus. Genet. Mol. Res. 2016, 15(2), 1–7. DOI: https://doi.org/10.4238/gmr.15028007.
- Yu-Hsiang, H.; Pei-Pei, H.; Ming-Shi, C. Interleukin-19 Blockade Attenuates Collagen-induced Arthritis in Rats. Rheumatology. 2012, 51, 434–442. DOI: https://doi.org/10.1093/rheumatology/ker127.